Our Thoracic Cancer Program specializes in the treatment of lung cancer, esophageal cancer and Barrett’s Esophagus, chest wall tumors and mediastinal tumors. We bring together specialists and sub-specialists into a highly-coordinated team for your care. You will get individualized attention from several specialists who will complete a thorough diagnostic review of your cancer. Then our team reviews the data and talks over the best possible treatment options with you and your family.
Our navigation teams provide personalized care coordination, connect patients with support resources, help prevent treatment delays, communicate with physicians and others on your team, and help patients understand their diagnosis and treatment options.
Lung cancer is the second most common cancer and the primary cause of cancer-related death in both men and women in the United States.
Cancer is personal. It can affect every part of your life. And not all cancers are created equal – what happens with one person’s disease can be completely different for someone else with the same type of cancer. That’s why we will look at your case in a way that’s as individual as you are, drawing on the expertise and knowledge gained from research at South Carolina’s only National Cancer Institute-Designated Cancer Center.
In an effort to reduce the cancer burden in our state, our experts are addressing tobacco-related cancers from all angles, including population sciences and disparities research, drug discovery and survivorship research.
Get to know Dr. Carol Sherman, a lung cancer specialist at the MUSC Hollings Cancer Center.
Along with state-of-the-art treatments, Hollings assists patients in dealing with the financial, physical and emotional aspects of having cancer.
When a spot was found on one of my lungs, Dr. Denlinger recommended a minimally-invasive procedure called VATs, or video-assisted thoracoscopic surgery. “Thanks to this procedure and the wonderful staff at MUSC, I’m cancer free and back to my active life in Hilton Head.”
Our clinical trials for lung and other thoracic cancers offer patients access to cutting-edge therapies that may not be available anywhere else.